Biotech Innovator InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of Worldwide Launch of Non-Injectable Peptide Platform

Backed by successful double-blinded pharmacokinetic study data and nine pending patents, the biotechnology pioneer prepares for the August 3 launch of five next-generation oral dissolving peptide films. SALT LAKE CITY, July 27, 2026 /PRNewswire/ -- InstaMed® Pharmaceuticals, an advanced...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.